Local Drug Delivery to Bladder Using Technology Innovations - 16/08/11
Doi : 10.1016/j.ucl.2006.06.012
Pradeep Tyagi, PhD a, ⁎ 
, Shachi Tyagi, MD a, Jonathan Kaufman, PhD, MBA b, Leaf Huang, PhD c, Fernando de Miguel, PhD a
, Shachi Tyagi, MD a, Jonathan Kaufman, PhD, MBA b, Leaf Huang, PhD c, Fernando de Miguel, PhD a a Department of Urology, University of Pittsburgh School of Medicine, Kaufmann Medical Building, Suite 700, 3471 Fifth Avenue, Pittsburgh, PA 15213-3221, USA
b Lipella Pharmaceuticals, Pittsburgh, PA, USA
c School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Corresponding author. Department of Urology, W326, Montefiore Hospital, 3459 Fifth Avenue, Pittsburgh, PA 15213.Plan
| This research was funded by grants from the National Institutes of Health (DK 068556), DK 066138, and the Fishbein Family Foundation (CURE-IC). |
© 2006
Elsevier Inc. Tous droits réservés.
Vol 33 - N° 4
P. 519-530 - novembre 2006 Retour au numéro
Article précédent
- Local Effects of Antimuscarinics
- Hitoshi Masuda, Yong-Tae Kim, Shachi Tyagi, Michael B. Chancellor, Fernando de Miguel, Naoki Yoshimura
- When to Use Antimuscarinics in Men Who Have Lower Urinary Tract Symptoms
- Ji Youl Lee, Dae Kyung Kim, Michael B. Chancellor
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?